Skip to main content
Top
Published in: Skeletal Radiology 3/2015

01-03-2015 | Case Report

Gemcitabine-induced radiation recall myositis

Authors: Joshua Adam Delavan, Junzo P. Chino, Emily N. Vinson

Published in: Skeletal Radiology | Issue 3/2015

Login to get access

Abstract

Radiation recall is an uncommon phenomenon in which administration of a chemotherapeutic agent induces an acute inflammatory reaction in previously irradiated tissues, often weeks to years after completion of radiotherapy. This entity is well known to medical and radiation oncologists, however only three cases have been reported in radiology journals. We present a case of gemcitabine-induced radiation recall that manifested as myositis with associated dermatitis in the posterior thigh of a patient with remote history of localized radiotherapy for biopsy-proven breast cancer metastasis. We also present a brief literature review to update the topic of radiation recall in imaging, and emphasize the importance of knowledge of this phenomenon when considering the differential diagnosis of myositis/dermatitis in a patient who has received cancer treatment.
Literature
1.
go back to reference D’Angio GJ, Farber S, Maddock CL. Potentiation of X-ray effects by actinomycin D. Radiology. 1959;73:175–7.PubMedCrossRef D’Angio GJ, Farber S, Maddock CL. Potentiation of X-ray effects by actinomycin D. Radiology. 1959;73:175–7.PubMedCrossRef
2.
go back to reference Eckardt MA, Bean A, Selch MT, Federman N. A child with gemcitabine-induced severe radiation recall myositis resulting in a compartment syndrome. J Pediatr Hematol Oncol. 2013;35(2):156–61.PubMedCrossRef Eckardt MA, Bean A, Selch MT, Federman N. A child with gemcitabine-induced severe radiation recall myositis resulting in a compartment syndrome. J Pediatr Hematol Oncol. 2013;35(2):156–61.PubMedCrossRef
3.
go back to reference Azria D, Magne N, Zouhair A, Castadot P, Culine S, Ychou M, et al. Radiation recall: a well-recognized but neglected phenomenon. Cancer Treat Rev. 2005;31(7):555–70.PubMedCrossRef Azria D, Magne N, Zouhair A, Castadot P, Culine S, Ychou M, et al. Radiation recall: a well-recognized but neglected phenomenon. Cancer Treat Rev. 2005;31(7):555–70.PubMedCrossRef
5.
go back to reference Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59(3):237–45.PubMedCrossRef Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59(3):237–45.PubMedCrossRef
6.
go back to reference Boal DK, Newburger PE, Teele RL. Esophagitis induced by combined radiation and adriamycin. AJR Am J Roentgenol. 1979;132(4):567–70.PubMedCrossRef Boal DK, Newburger PE, Teele RL. Esophagitis induced by combined radiation and adriamycin. AJR Am J Roentgenol. 1979;132(4):567–70.PubMedCrossRef
7.
go back to reference Ma LD, Taylor GA, Wharam MD, Wiley JM. "Recall" pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology. 1993;187(2):465–7.PubMedCrossRef Ma LD, Taylor GA, Wharam MD, Wiley JM. "Recall" pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology. 1993;187(2):465–7.PubMedCrossRef
8.
go back to reference Garza LA, Yoo EK, Junkins-Hopkins JM, VanVoorhees AS. Photo recall effect in association with cefazolin. Cutis. 2004;73(1):79–80. 5.PubMed Garza LA, Yoo EK, Junkins-Hopkins JM, VanVoorhees AS. Photo recall effect in association with cefazolin. Cutis. 2004;73(1):79–80. 5.PubMed
9.
go back to reference Extermann M, Vogt N, Forni M, Dayer P. Radiation recall in a patient with breast cancer treated for tuberculosis. Eur J Clin Pharmacol. 1995;48(1):77–8.PubMedCrossRef Extermann M, Vogt N, Forni M, Dayer P. Radiation recall in a patient with breast cancer treated for tuberculosis. Eur J Clin Pharmacol. 1995;48(1):77–8.PubMedCrossRef
11.
go back to reference Bostrom A, Sjolin-Forsberg G, Wilking N, Bergh J. Radiation recall–another call with tamoxifen. Acta Oncol. 1999;38(7):955–9.PubMedCrossRef Bostrom A, Sjolin-Forsberg G, Wilking N, Bergh J. Radiation recall–another call with tamoxifen. Acta Oncol. 1999;38(7):955–9.PubMedCrossRef
12.
go back to reference Singer EA, Warren RD, Pennanen MF, Collins BT, Hayes DF. Tamoxifen-induced radiation recall dermatitis. Breast J. 2004;10(2):170–1.PubMedCrossRef Singer EA, Warren RD, Pennanen MF, Collins BT, Hayes DF. Tamoxifen-induced radiation recall dermatitis. Breast J. 2004;10(2):170–1.PubMedCrossRef
13.
go back to reference Abadir R, Liebmann J. Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol (R Coll Radiol). 1995;7(5):325–6.PubMedCrossRef Abadir R, Liebmann J. Radiation reaction recall following simvastatin therapy: a new observation. Clin Oncol (R Coll Radiol). 1995;7(5):325–6.PubMedCrossRef
14.
go back to reference Del Guidice SM, Gerstley JK. Sunlight-induced radiation recall. Int J Dermatol. 1988;27(6):415–6.PubMedCrossRef Del Guidice SM, Gerstley JK. Sunlight-induced radiation recall. Int J Dermatol. 1988;27(6):415–6.PubMedCrossRef
15.
16.
go back to reference Burdon J, Bell R, Sullivan J, Henderson M. Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA. 1978;239(10):931.PubMedCrossRef Burdon J, Bell R, Sullivan J, Henderson M. Adriamycin-induced recall phenomenon 15 years after radiotherapy. JAMA. 1978;239(10):931.PubMedCrossRef
17.
go back to reference Barlesi F, Tummino C, Tasei AM, Astoul P. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. Lung Cancer. 2006;54(3):423–5.PubMedCrossRef Barlesi F, Tummino C, Tasei AM, Astoul P. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. Lung Cancer. 2006;54(3):423–5.PubMedCrossRef
18.
go back to reference Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer. 2004;100(9):1793–9.PubMedCrossRef Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner J, Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer. 2004;100(9):1793–9.PubMedCrossRef
19.
go back to reference Pentsova E, Liu A, Rosenblum M, O’Reilly E, Chen X, Hormigo A. Gemcitabine-induced myositis in patients with pancreatic cancer: case reports and topic review. J Neurooncol. 2012;106(1):15–21.PubMedCrossRef Pentsova E, Liu A, Rosenblum M, O’Reilly E, Chen X, Hormigo A. Gemcitabine-induced myositis in patients with pancreatic cancer: case reports and topic review. J Neurooncol. 2012;106(1):15–21.PubMedCrossRef
20.
go back to reference Saif MW, Sellers S, Russo S. Gemcitabine-related radiation recall in a patient with pancreatic cancer. Anticancer Drugs. 2006;17(1):107–11.PubMedCrossRef Saif MW, Sellers S, Russo S. Gemcitabine-related radiation recall in a patient with pancreatic cancer. Anticancer Drugs. 2006;17(1):107–11.PubMedCrossRef
21.
go back to reference Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002;53(2):394–400.PubMedCrossRef Jeter MD, Janne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002;53(2):394–400.PubMedCrossRef
Metadata
Title
Gemcitabine-induced radiation recall myositis
Authors
Joshua Adam Delavan
Junzo P. Chino
Emily N. Vinson
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 3/2015
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-014-1996-1

Other articles of this Issue 3/2015

Skeletal Radiology 3/2015 Go to the issue

Browser's Notes

Browser's Notes